<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Hospitalist &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/hospitalist/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>ACE inhibitor treated hypertension linked to reduced all-cause mortality</title>
		<link>http://www.thedoctorschannel.com/view/ace-inhibitor-treated-hypertension-linked-to-reduced-all-cause-mortality/</link>
		<pubDate>Wed, 16 May 2012 15:39:22 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Home Page Featured]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[ACE inhibitor]]></category>
		<category><![CDATA[angiotensin]]></category>
		<category><![CDATA[hypertension]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31830</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include an ACE inhibitor, according to the results of a meta-analysis reported in the European Heart Journal online April 17. “In view of the high prevalence of hypertension -]]></description>
		
			<media:content duration="1:23" medium="video">
		<media:title><![CDATA[ACE inhibitor treated hypertension linked to reduced all-cause mortality]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include an ACE inhibitor, according to the results of a meta-analysis reported in the European Heart Journal online April 17. “In view of the high prevalence of hypertension -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/ace-inhibitor-treated-hypertension-linked-to-reduced-all-cause-mortality/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120516epid004.jpg"/>
	<media:keywords><![CDATA[ACE inhibitor,angiotensin,hypertension]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Aspirin use doesn&#8217;t curb peptic ulcer healing</title>
		<link>http://www.thedoctorschannel.com/view/aspirin-use-doesnt-curb-peptic-ulcer-healing/</link>
		<pubDate>Tue, 15 May 2012 18:56:57 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[aspirin]]></category>
		<category><![CDATA[esomeprazole]]></category>
		<category><![CDATA[peptic ulcer]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31795</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; In patients with aspirin-related peptic ulcers, ulcer healing rates are comparable after esomeprazole therapy with or without aspirin continuation, Taiwanese researchers report in an April 17th on-line paper in The American Journal of Gastroenterology. In fact, the investigators suggest that &#8220;continuing low-dose aspirin plus a proton pump inhibitor is the -]]></description>
		
			<media:content duration="1:34" medium="video">
		<media:title><![CDATA[Aspirin use doesn&#8217;t curb peptic ulcer healing]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; In patients with aspirin-related peptic ulcers, ulcer healing rates are comparable after esomeprazole therapy with or without aspirin continuation, Taiwanese researchers report in an April 17th on-line paper in The American Journal of Gastroenterology. In fact, the investigators suggest that &#8220;continuing low-dose aspirin plus a proton pump inhibitor is the -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/aspirin-use-doesnt-curb-peptic-ulcer-healing/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120515clin005.jpg"/>
	<media:keywords><![CDATA[aspirin,esomeprazole,peptic ulcer]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Higher beta-blocker dose lowers mortality in heart failure patients</title>
		<link>http://www.thedoctorschannel.com/view/higher-beta-blocker-dose-lowers-mortality-in-heart-failure-patients-2/</link>
		<pubDate>Wed, 09 May 2012 21:43:01 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[beta-blocker]]></category>
		<category><![CDATA[Heart Failure]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31316</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Confirming recommendations, titrating beta-blocker dosage in ambulatory patients with heart failure up to an equivalent of 50 mg/d carvedilol reduces all-cause deaths and hospitalizations, according to a report in the July 17 issue of the Journal of the American College of Cardiology. “There was no increase in bradycardia with higher -]]></description>
		
			<media:content duration="1:27" medium="video">
		<media:title><![CDATA[Higher beta-blocker dose lowers mortality in heart failure patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Confirming recommendations, titrating beta-blocker dosage in ambulatory patients with heart failure up to an equivalent of 50 mg/d carvedilol reduces all-cause deaths and hospitalizations, according to a report in the July 17 issue of the Journal of the American College of Cardiology. “There was no increase in bradycardia with higher -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/higher-beta-blocker-dose-lowers-mortality-in-heart-failure-patients-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120509clin001.jpg"/>
	<media:keywords><![CDATA[beta-blocker,Heart Failure]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Nutritional support does seem to help malnourished COPD patients</title>
		<link>http://www.thedoctorschannel.com/view/nutritional-support-does-seem-to-help-malnourished-copd-patients/</link>
		<pubDate>Mon, 07 May 2012 18:36:48 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pulmonary Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[COPD]]></category>
		<category><![CDATA[malnourished]]></category>
		<category><![CDATA[nutrition]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31083</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Nutritional support, mainly in the form of oral nutritional supplements, boosts protein and energy intake, body weight and grip strength in malnourished patients with chronic obstructive pulmonary disease (COPD), according to results of a new systematic review and meta-analysis of relevant research. In a report online April 18 in the -]]></description>
		
			<media:content duration="1:44" medium="video">
		<media:title><![CDATA[Nutritional support does seem to help malnourished COPD patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Nutritional support, mainly in the form of oral nutritional supplements, boosts protein and energy intake, body weight and grip strength in malnourished patients with chronic obstructive pulmonary disease (COPD), according to results of a new systematic review and meta-analysis of relevant research. In a report online April 18 in the -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/nutritional-support-does-seem-to-help-malnourished-copd-patients/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120507clin003.jpg"/>
	<media:keywords><![CDATA[COPD,malnourished,nutrition]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Twice-daily aclidinium improves bronchodilation in COPD patients</title>
		<link>http://www.thedoctorschannel.com/view/twice-daily-aclidinium-improves-bronchodilation-in-copd-patients/</link>
		<pubDate>Tue, 17 Apr 2012 20:08:49 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Pulmonary Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Aclidinium]]></category>
		<category><![CDATA[COPD]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=28292</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – In patients with moderate-to-severe chronic obstructive pulmonary disease, twice daily inhalation of either 200 or 400 mcg aclidinium bromide significantly improves FEV1, and results are sustained after 24 weeks, according to a report in the European Respiratory Journal online March 22. “With both aclidinium doses, the incidence of anticholinergic adverse -]]></description>
		
			<media:content duration="1:31" medium="video">
		<media:title><![CDATA[Twice-daily aclidinium improves bronchodilation in COPD patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – In patients with moderate-to-severe chronic obstructive pulmonary disease, twice daily inhalation of either 200 or 400 mcg aclidinium bromide significantly improves FEV1, and results are sustained after 24 weeks, according to a report in the European Respiratory Journal online March 22. “With both aclidinium doses, the incidence of anticholinergic adverse -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/twice-daily-aclidinium-improves-bronchodilation-in-copd-patients/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120417drgd002.jpg"/>
	<media:keywords><![CDATA[Aclidinium,COPD]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Fecal microbiota transplant effective for recurrent C difficile infection</title>
		<link>http://www.thedoctorschannel.com/view/fecal-microbiota-transplant-effective-for-recurrent-c-difficile-infection/</link>
		<pubDate>Tue, 10 Apr 2012 23:06:18 +0000</pubDate> 
				<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[c difficile]]></category>
		<category><![CDATA[Fecal transplant]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27891</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Instillation of donor fecal material in the colon of patients with recurrent Clostridium difficile infection leads to rapid resolution of the condition in more than 90% of cases, investigators report in the American Journal of Gastroenterology online March 29. “Evidence continues to mount showing that FMT (fecal microbiota transplant) is -]]></description>
		
			<media:content duration="1:39" medium="video">
		<media:title><![CDATA[Fecal microbiota transplant effective for recurrent C difficile infection]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Instillation of donor fecal material in the colon of patients with recurrent Clostridium difficile infection leads to rapid resolution of the condition in more than 90% of cases, investigators report in the American Journal of Gastroenterology online March 29. “Evidence continues to mount showing that FMT (fecal microbiota transplant) is -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/fecal-microbiota-transplant-effective-for-recurrent-c-difficile-infection/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120410drgd001.jpg"/>
	<media:keywords><![CDATA[c difficile,Fecal transplant]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>High-concentration oxygen therapy for uncomplicated STEMI of little value, study confirms</title>
		<link>http://www.thedoctorschannel.com/view/high-concentration-oxygen-therapy-for-uncomplicated-stemi-of-little-value-study-confirms/</link>
		<pubDate>Fri, 16 Mar 2012 13:39:28 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[High-concentration oxygen]]></category>
		<category><![CDATA[myocardial infarction]]></category>
		<category><![CDATA[STEMI]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26846</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Results of a randomized study provide no evidence of benefit from high-concentration oxygen therapy relative to titrated oxygen therapy in patients with initially uncomplicated ST-elevation myocardial infarction (STEMI). “The indoctrinated treatment concept that all patients experiencing a heart attack should receive high-concentration oxygen therapy is not supported by available evidence,” -]]></description>
		
			<media:content duration="1:41" medium="video">
		<media:title><![CDATA[High-concentration oxygen therapy for uncomplicated STEMI of little value, study confirms]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Results of a randomized study provide no evidence of benefit from high-concentration oxygen therapy relative to titrated oxygen therapy in patients with initially uncomplicated ST-elevation myocardial infarction (STEMI). “The indoctrinated treatment concept that all patients experiencing a heart attack should receive high-concentration oxygen therapy is not supported by available evidence,” -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/high-concentration-oxygen-therapy-for-uncomplicated-stemi-of-little-value-study-confirms/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120316drgd009.jpg"/>
	<media:keywords><![CDATA[High-concentration oxygen,myocardial infarction,STEMI]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Renin-angiotensin blockade helpful in heart failure with renal disease</title>
		<link>http://www.thedoctorschannel.com/view/renin-angiotensin-blockade-helpful-in-heart-failure-with-renal-disease/</link>
		<pubDate>Fri, 09 Mar 2012 22:59:41 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nephrology]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[ACE inhibitor]]></category>
		<category><![CDATA[ARB]]></category>
		<category><![CDATA[chronic kidney disease]]></category>
		<category><![CDATA[CKD]]></category>
		<category><![CDATA[Heart Failure]]></category>
		<category><![CDATA[renin-angiotensin]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26379</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – The benefit of renin-angiotensin system inhibition in systolic heart failure (HF) extends to older patients with chronic kidney disease (CKD), a new study suggests. The study found that being prescribed an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) at hospital discharge was associated with a “significant modest” 14% -]]></description>
		
			<media:content duration="1:43" medium="video">
		<media:title><![CDATA[Renin-angiotensin blockade helpful in heart failure with renal disease]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – The benefit of renin-angiotensin system inhibition in systolic heart failure (HF) extends to older patients with chronic kidney disease (CKD), a new study suggests. The study found that being prescribed an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) at hospital discharge was associated with a “significant modest” 14% -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/renin-angiotensin-blockade-helpful-in-heart-failure-with-renal-disease/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120309clin010.jpg"/>
	<media:keywords><![CDATA[ACE inhibitor,ARB,chronic kidney disease,CKD,Heart Failure,renin-angiotensin]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Papaverine improves analgesia for renal colic</title>
		<link>http://www.thedoctorschannel.com/view/papaverine-improves-analgesia-for-renal-colic/</link>
		<pubDate>Wed, 07 Mar 2012 21:50:50 +0000</pubDate> 
				<category><![CDATA[Emergency Medicine]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Urology]]></category>
		<category><![CDATA[papaverine]]></category>
		<category><![CDATA[renal colic]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26109</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Pain associated with acute renal colic is relieved more effectively when intravenous papaverine is added to treatment with diclofenac suppository, an Iranian team reports in BJU International online February 20. “We think that this method could reduce the usage of opioids and NSAIDs in the treatment of renal colic,” the -]]></description>
		
			<media:content duration="01:24" medium="video">
		<media:title><![CDATA[Papaverine improves analgesia for renal colic]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Pain associated with acute renal colic is relieved more effectively when intravenous papaverine is added to treatment with diclofenac suppository, an Iranian team reports in BJU International online February 20. “We think that this method could reduce the usage of opioids and NSAIDs in the treatment of renal colic,” the -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/papaverine-improves-analgesia-for-renal-colic/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120307drgd005.jpg"/>
	<media:keywords><![CDATA[papaverine,renal colic]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Vena cava filters cut pulmonary embolism fatalities in some categories of patients</title>
		<link>http://www.thedoctorschannel.com/view/vena-cava-filters-cut-pulmonary-embolism-fatalities-in-some-categories-of-patients/</link>
		<pubDate>Tue, 06 Mar 2012 21:43:28 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Critical Care]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[pulmonary embolism]]></category>
		<category><![CDATA[thrombolytic]]></category>
		<category><![CDATA[vena cava filter]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26081</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Data from the National Inpatient Sample indicate that vena cava filters reduce the in-hospital fatality rate among patients with pulmonary embolism who are unstable and in those who are stable and received thrombolytic therapy. “The majority of hospitalized patients with pulmonary embolism, however, were stable and did not receive thrombolytic -]]></description>
		
			<media:content duration="01:44" medium="video">
		<media:title><![CDATA[Vena cava filters cut pulmonary embolism fatalities in some categories of patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Data from the National Inpatient Sample indicate that vena cava filters reduce the in-hospital fatality rate among patients with pulmonary embolism who are unstable and in those who are stable and received thrombolytic therapy. “The majority of hospitalized patients with pulmonary embolism, however, were stable and did not receive thrombolytic -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/vena-cava-filters-cut-pulmonary-embolism-fatalities-in-some-categories-of-patients/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120306clin001.jpg"/>
	<media:keywords><![CDATA[pulmonary embolism,thrombolytic,vena cava filter]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
